Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis B Reactivation 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × tenofovir alafenamide × Clear all
NCT04619082 2024-11-12

TAF to Prevent HBV Reactivation in Cancer Patients

Chiayi Christian Hospital

Phase 4 Active not recruiting
102 enrolled

Hepatitis B Reactivation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡